Limited and External Funding Opportunities

Contact us...

  • Email LSO@vanderbilt.edu if you are interested in an opportunity not listed below or have questions regarding the LSO submission process.

 

Have you been awarded a Limited Submission recognition?

Please let us know at LSO@vanderbilt.edu


Research Awards Banner.png

Active Internal Calls for Limited Submission Nominations 

Internal review process required to choose institutional nominees


Limited Submission Eligibility Guidelines

The following tags serve as a guide for submission instructions.

 Vanderbilt (VU + VUMC):  

  • VU and VUMC submit collaboratively to this LSO. ALL investigators should follow the guidelines posted on this site.

 VUMC :

  • VU and VUMC submit separately to this LSO. VUMC investigators should follow the guidelines posted on this site. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

FEATURED OPPORTUNITY

  • High-profile or prestigious awards of particular interest to Vanderbilt investigators

2023 Centers for Disease Control Programmatic Interventions to Increase Uptake of Influenza and COVID-19 Vaccination Among Students Attending Institutions of Higher Education

Applications due December 7, 2022

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu

Overview

VUMC may submit one application to the CDC Programmatic Interventions to Increase Uptake of Influenza and COVID-19 Vaccination Among Students Attending Institutions of Higher Education funding opportunity. The purpose of this opportunity is to conduct research to investigate the following: 1) knowledge and attitudes about influenza and COVID-19 vaccination and mandates among undergraduate students attending Institutes of Higher Education (IHE); 2) barriers and factors associated with the likelihood of influenza and COVID-19 vaccine uptake; 3) effectiveness of one or more approaches to increase influenza and COVID-19 vaccination coverage among undergraduate students; and 4) cost assessment of the intervention(s). Students attending IHEs are a population at higher risk of infection with influenza viruses and SARS-CoV-2 due to unique exposures, including living in dormitories, attending in-person classes, and participating in social activities. Staying up to date with annual influenza and COVID-19 vaccines is recommended to reduce the risk of infection by these viruses.

The recipient of this award should recruit at least 16 institutes of higher education (IHEs ), half of which have instituted a mandate for influenza or COVID-19 vaccination and half of which have not instituted a mandate(s). The IHEs selected should have similar key characteristics: 4-year IHE, proportion of students living in on-campus housing, and proportion of students enrolled in in-person classes. The award recipient should work with the selected IHEs to conduct the following activities:

  1. A web-based pre-intervention survey to assess knowledge and attitudes about influenza and COVID-19 vaccination among undergraduate students, barriers to, and factors associated with, the likelihood of getting influenza and covid-19 vaccinations, and general attitudes about vaccines and vaccine mandates.
  2. Identify appropriate interventions, informed by results of the pre-intervention survey as well as relevant research, and design and implement a program to assess one more intervention to increase undergraduate student influenza and COVID-19 vaccination coverage in the IHEs with no vaccination mandates in place. Participating IHEs that do not have a mandate should be randomized to control and intervention groups.
  3. A web-based post-intervention survey of students attending IHEs randomized to receive the intervention. Post-surveys will assess knowledge, attitudes, and history of influenza and COVID-19 vaccination among undergraduate students attending IHEs without mandates after the intervention program has been implemented. The survey will also assess factors associated with likelihood of getting influenza and COVID-19 vaccination among all students as well as acceptability and awareness of the intervention(s) among those students attending IHEs randomized to receive the intervention.
  4. A cost analysis of each implemented intervention.

Assessment of study outcomes: Intervention effectiveness should be assessed via the pre- and post-intervention surveys by comparing study groups on the following outcomes:

  1. Changes in knowledge of, and attitudes towards, influenza and COVID-19 vaccination among undergraduate students attending IHEs.
  2. Changes in self-reported influenza and COVID-19 vaccination coverage among undergraduate students.
  3. Feasibility and acceptability of the intervention(s) from the undergraduate student perspective among students in the intervention arm.

Award Information

The estimated total funding for this award, including direct and indirect costs, is $1,500,000 over a 3 year project period.

See the NOFO for more information.

Internal Application Information

Anyone interested in being considered to submit one of VUMC’s proposals must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on December 7, 2022:

  1. Brief (2 page maximum) project description
  2. Letter of support from department chair/center director
  3. NIH Biosketch

The chosen nominee will submit a full proposal to the sponsor by the deadline of January 13, 2023.

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


2023 Mary Kay Ash Foundation Innovative/Translational Cancer Research Grant

Vanderbilt (VU + VUMC): This is a combined competition for VU and VUMC investigators. All investigators should follow these instructions.

Applications due December 8, 2022

VU and VUMC may each nominate one candidate for the Mary Kay Foundation Innovative/Translational Cancer Research Grant program for 2023. These awards provide $100,000 over two years to support innovative translational research for cancers affecting women, including but not limited to ovarian, uterine, breast, endometrial and/or cervical cancer.

The Foundation seeks to fund innovative research that will provide a scientific link between laboratory research and the clinic. Ultimately, such research would lead to improvement in the diagnosis, prognosis, prevention, or treatment of cancer.

You can find a list of the previous award recipients here. Review additional guidelines in the RFP.

Eligibility:

  • Principal Investigator must be Full-time Assistant Professor or higher (Assistant, Associate, or Full Professor) and commit a minimum 5% effort.
  • Staff scientists, postdoctoral trainees and instructors are NOT eligible.
  • Up to one co-PI is permitted. Co-PI must meet the same eligibility requirements as PI (Assistant Professor or higher).
  • Post-doc contributors may be listed as co-investigator, but not co-PI.
  • The maximum total budget is $100,000. Indirect costs may not exceed 15% of direct costs (E.g., Direct costs ≤ $86,956, Indirect costs ≤ $13,044.)
  • U.S. citizenship is not required.

Internal Application Process:

Anyone interested in being considered as VU or VUMC’s nominee must submit the following to LSO@vanderbilt.edu by 5 p.m. on December 8Please combine your materials into a single PDF and reference the program name in the subject line of the email. 

  1. Brief research plan including summary budget (2 page max);
  2. Statement of support from department chair/center director;
  3. NIH Biosketch or brief CV (5 page max)

The chosen nominee will submit a full proposal to the Foundation by the deadline of February 1, 2023. Direct all questions about this opportunity to LSO@vanderbilt.edu.


2023 NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00)

Applications due December 8, 2022

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.

Overview

VU and VUMC may each submit one application per scientific focus area to the NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00) programs. The scientific focus areas are Data Science, Cancer Control Science, and Other Sciences. There are three separate RFAs, which allow different types of proposed research (e.g. basic, clinical): RFA-CA-22-035RFA-CA-22-036, and RFA-CA-22-037. VU’s three selected applicants (1/focus area) may apply to whichever RFAs best suit their research proposals.

The objective of the NCI Pathway to Independence Award is to help outstanding postdoctoral researchers complete needed, mentored career training and transition in a timely manner to independent tenure-track (or equivalent) faculty positions. The K99/R00 award is intended to foster the development of a creative, independent research program that will be competitive for subsequent independent funding and that will help advance the mission of the NCI.

This program is designed for outstanding postdoctoral fellows with research and/or clinical doctoral degrees who do not require extended periods of mentored research training beyond their original doctoral degrees before transitioning to research independence. Researchers in the scientific areas of data science and cancer control science are especially encouraged to apply.

Individuals must be in mentored, postdoctoral training positions to be eligible to apply to the K99/R00 program. The K99/R00 award will provide up to 5 years of support in two phases. The initial (K99) phase will provide support for up to 2 years of mentored postdoctoral research training and career development. The second (R00) phase will provide up to 3 years of independent research support, which is contingent on satisfactory progress during the K99 phase and obtaining an approved, independent tenure-track (or equivalent) faculty position.

The award covers up to $100,000 per year toward the salary of the career award recipient, and up to $30,000 per year toward the research development costs of the award recipient.

See solicitations for full program and eligibility details:

RFA-CA-22-035 - Independent Clinical Trial Not Allowed

RFA-CA-22-036 - Independent Clinical Trial Required

RFA-CA-22-037 - Independent Basic Experimental Studies with Humans Required

Internal Application Process:

Anyone interested in being considered to submit a proposal must submit the following materials by 5 p.m. on December 8. Note the different submission instructions for VU and VUMC postdocs, below.

  1. Brief (2-page maximum) research plan including summary budget;
  2. Statement of support from department chair/center director;
  3. NIH Biosketch

For VU-employed Postdocs:

  • Submit all application materials via InfoReady by December 8, 2022 at the following link: https://vanderbilt.infoready4.com/#competitionDetail/1886447
  • In your application, indicate to which RFA and which scientific focus area (data science, cancer control science, other sciences) you would apply.
  • Any questions about this opportunity, eligibility, or the LSO process may be directed to VU-LSO@vanderbilt.edu.

For VUMC-employed Postdocs:

  • Submit all application materials in a single PDF to lso@vanderbilt.edu by December 8, 2022. Visit the OOR site for more detail.
  • In your email, indicate to which RFA and which scientific focus area (data science, cancer control science, other sciences) you would apply.
  • Any questions about this opportunity, eligibility, or the LSO process may be directed to LSO@vanderbilt.edu.

NSF Scholarships in Science, Technology, Engineering, Mathematics (S-STEM)

Applications are due December 9, 2022

Vanderbilt (VU + VUMC): This is a combined competition for VU and VUMC investigators. All investigators should follow these instructions.

Vanderbilt University may submit no more than two proposals (either as a single institution or as subawardee or a member of an inter-institutional consortia project) to the NSF Scholarships in Science, Technology, Engineering, and Mathematics Program (S-STEM).

The main goal of the S-STEM program is to enable low-income students with academic ability, talent or potential to pursue successful careers in promising STEM fields. Recognizing that financial aid alone cannot increase retention and graduation in STEM, the program provides awards to institutions of higher education (IHEs) not only to fund scholarships, but also to adapt, implement, and study evidence-based curricular and co-curricular activities that have been shown to be effective supporting recruitment, retention, transfer (if appropriate), student success, academic/career pathways, and graduation in STEM.

The program seeks to 1) increase the number of low-income academically talented students with demonstrated financial need obtaining degrees in S-STEM eligible disciplines and entering the US workforce or graduate programs in STEM; 2) improve support mechanisms for future scientists, engineers, and technicians, with a focus on low-income academically talented students with demonstrated financial need; and 3) advance our understanding of how interventions or evidence-based curricular and co-curricular activities affect the success, retention, transfer, academic/career pathways, and graduation of low-income students in STEM.

The S-STEM program encourages collaborations, including but not limited to partnerships among different types of institutions; collaborations of S-STEM eligible faculty, researchers, and academic administrators; and partnerships among institutions of higher education and business, industry, local community organizations, national labs, or other federal or state government organizations, as appropriate.

Scholars must be domestic low-income students, with academic ability, talent or potential and with demonstrated unmet financial need who are enrolled in an associate, baccalaureate, or graduate degree program in an S-STEM eligible discipline. Proposers must provide an analysis that articulates the characteristics and academic needs of the population of students they are trying to serve. NSF is particularly interested in supporting the attainment of degrees in fields identified as critical needs for the Nation. Many of these fields have high demand for training professionals that can operate at the convergence of disciplines and include but are not limited to quantum computing and quantum science, robotics, artificial intelligence and machine learning, computer science, data science and computational science applied to other frontier STEM areas and other STEM or technology fields in urgent need of domestic professionals. It is up to the proposer to make a compelling case that a field is a critical need field in the United States.

S-STEM Eligible Degree Programs

  • Associate of Arts, Associate of Science, Associate of Engineering, and Associate of Applied Science
  • Bachelor of Arts, Bachelor of Science, Bachelor of Engineering and Bachelor of Applied Science
  • Master of Arts, Master of Science and Master of Engineering
  • Doctoral

S-STEM Eligible Disciplines

  • Disciplinary fields in which research is funded by NSF, with the following exceptions:
    1. Clinical degree programs, including medical degrees, nursing, veterinary medicine, physical therapy, and others not funded by NSF, are ineligible degrees.
    2. Business school programs that lead to Bachelor of Arts or Science in Business Administration degrees (BABA/BSBA/BBA) are not eligible for S-STEM funding.
    3. Masters and Doctoral degrees in Business Administration are also excluded.
  • Technology fields associated with the S-STEM-eligible disciplines (e.g., biotechnology, chemical technology, engineering technology, information technology).

Note that there are 3 Tracks and a Collaborative Planning grant mechanism for which an application can be submitted and each track has its own separate budgetary considerations. The proposal limits apply only to Tracks 1-3, not to Collaborative Planning grants.

Track 1: Institutional Capacity Building; may request up to $750,000 for up to 6 years.

-Track 1 projects seek to increase the participation of institutions that have never had an award from the S-STEM program or the STEM Talent Expansion (STEP) program. This requirement applies to the institution as whole. One S-STEM or STEP award to any department or school within the institution makes the entire institution ineligible for a Track 1 award.

Track 2: Implementation-Single Institution; may request up to $1,500,000 for 6 years.

-Track 2 proposals have the same S-STEM goals as Track 1 proposals. They involve only one institution, but they will serve more Scholars than Track 1 proposals. Any IHE (as described under the eligibility section) can submit a Track 2 proposal, whether or not the institution has received prior S-STEM or STEP awards.

Track 3: Inter-institutional Consortia; may request up to $5 million for up to 6 years

-Track 3 projects support multi-institutional collaborations that focus on a common interest or problem. For example, a collaboration among community colleges and four-year institutions may focus on issues associated with successful student transfer from 2-year institutions to 4-year programs. In another example, a multi-institutional collaboration may focus on investigating factors, such as self-efficacy or identity, that contribute to the success or degree attainment of domestic, low income students in different types of institutions.

Collaborative Planning Grants to Develop an Inter-institutional Consortium; may request up to $100,000 for one year (***Note that the proposal limits do not apply to collaborative planning grant proposals.)

Collaborative Planning projects provide support for groups of two or more IHEs and other potential partner organizations to establish fruitful collaborations, increase understanding of complex issues faced by low-income students at each institution, establish inter-institutional agreements when necessary and develop mechanisms for cooperation in anticipation of a future Track 3 proposal that will benefit all institutions and their scholars as equal partners.

This category of projects aims to provide proposers from two or more institutions the funds and time to establish the relationships and agreements necessary for submitting an Inter-institutional Consortia S-STEM proposal. It is expected that proposers will be ready to write and submit this Inter-institutional Consortia proposal within 1-2 years of receiving a Collaborative Planning grant award. Any subsequent proposals to S-STEM based on this work must describe the results of the planning effort.

See the solicitation for more details.

Internal Application Information

Anyone interested in being considered as Vanderbilt University’s institutional nominee must submit the following (in a single PDF) via InfoReady at https://vanderbilt.infoready4.com/#competitionDetail/1886372  by 5 p.m. on December 9, 2022:

  1. Brief (2-page maximum) research plan including summary budget;
  2. Recent Biographical Sketch or CV
  3. (optional) A letter of support from your department chair/center director/other

The chosen nominee will submit a full proposal to NSF by the deadline of February 20, 2023.
 

Any questions about this opportunity or the LSO process may be directed to VU-LSO@vanderbilt.edu.


2023 NIEHS Outstanding New Environmental Scientist (ONES) Award

Applications due December 12, 2022

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu

VUMC may submit one application to the NIH National Institute of Environmental Health Sciences (NIEHS) Outstanding New Environmental Scientist (ONES) Program.

The Outstanding New Environmental Scientist (ONES) Award is intended to identify the most talented Early Stage Investigators (ESIs) who intend to make a long-term commitment to research in the Environmental Health Sciences and assist them in launching an innovative research program focused on the understanding of environmental exposure effects on people's health.

The ONES Program is specifically targeted to Early Stage Investigators and program goals include career promotion as well as the scientific project proposed. Applications for the ONES program differ from standard R01 applications in that applicants must describe plans for the active participation of an external advisory committee to provide consultation and feedback on the research and career guidance, commitment by the institution to actively support the research program development of the Program Director/Principal Investigator (PD/PI), and a plan for career enhancement which will provide a strong foundation for future research endeavors.

Research projects proposed will be expected to have a defined impact on the environmental health sciences and be responsive to the mission of the NIEHS and the 2018-2023 Strategic Plan: Advancing Science, Improving Health: A Plan for Environmental Health Sciences Research. Applicants should consult the strategic plan to ensure that the research proposed in their application addresses the goals and priority areas of the NIEHS.

Award Information

The budget for direct costs is composed of two elements - research direct costs and career enhancement costs. For most applications, the budget for direct costs should be limited to $250,000 per year. With strong justification, research projects which have inherently higher costs may request direct costs of up to $400,000 per year. Career enhancement direct costs are limited to $250,000, which can be distributed over the 5-year award period. Note: the total direct cost budget (research plus career enhancement) may not exceed $475,000 in any year of the award.

Eligibility:

  • PD/PIs must be NIH defined Early Stage Investigators. See https://grants.nih.gov/grants/new_investigators/index.htm
  • PD/PIs must have faculty appointments which are tenure track or equivalent, generally at the level of Assistant Professor, and have demonstrated outstanding abilities in basic, clinical, quantitative, or population-based research. Individuals must have established research independence from a mentor, and have dedicated, independent laboratory space or access to the clinical, population-based and/or public health research resources which will allow them to conduct the research proposed in the grant application as the lead, independent PD/PI.
  • Applications must have a research focus on exposure-health related responses from environmental agents within the mission interest of the NIEHS, and may focus on: industrial chemicals or manufacturing byproducts, metals, pesticides, herbicides, air pollutants and other inhaled toxicants, particulates or fibers, fungal, and bacterial or biologically derived toxins
  • Applications may not focus exclusively/primarily on: alcohol, chemotherapeutic agents, radiation that is not a result of an ambient environmental exposure, smoking, except when considered as a secondary smoke exposure as a component in the indoor environment (particularly in children), drugs of abuse, pharmaceuticals, dietary nutrients, and infectious or parasitic agents.

See the solicitation for more details.

Internal Application Process:

Anyone interested in being considered as VUMC’s institutional applicant must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on December 12, 2022:

  1. Brief (2-page maximum) research plan including summary budget;
  2. Statement of support from department chair/center director;
  3. NIH Biosketch

The chosen nominee will submit a full proposal to NIH by the deadline of February 24, 2023, with an LOI due 30 days prior.

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


2023 Nashville Predators Foundation Helper Grants

Applications due December 12, 2022

VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Overview

Vanderbilt University may submit one application to the 2023 Nashville Predators Foundation Helper Grants. The foundation is offering funding to support projects/programs serving the Nashville or Middle Tennessee area. Projects must specifically benefit youth and their families.

Funds may be used for:

  • Specific Projects
  • Durable Goods
  • One-time Programs

Funds may not be used for:

  • General operating costs
  • Staff salaries
  • Sponsorship or fundraising of any kind
  • Capital campaigns
  • Endowments or reserve funds or grants to individuals
  • PTAs or Booster Clubs

Organizations looking to partner with the Nashville Predators and the Nashville Predators Foundation beyond funding are given stronger consideration.
 

The chosen nominee will submit a proposal to the sponsor by the deadline of January 13th, 2023. The foundation will notify applicants via email in early April, and funding is distributed by early May.

Award Information

Grants may range from $500 to a maximum of $10,000, with an average grant size of $4,000 in recent years. The foundation does not accept requests for funding projects in April or May of the application year. It is however acceptable to request funding for a project in April or May of the following year.


See the program page for more information.

Internal Submission Instructions

Anyone interested in being considered as VUMC’s nominee must submit the following as a single file (in PDF format) to LSO@vanderbilt.edu by 5:00 pm on December 12, 2022.

  1. Brief (2 page max) description of your project, including summary budget. Please include a brief description of the following:
    1. Project goals, objectives, timetables and metrics
    2. Plans for dissemination of project outcomes
    3. Impact on the community
    4. Brief statement on how this project aligns with the Predators Foundation vision and mission.
  2. Letter of support from department chair/center director
  3. NIH biosketch or Brief CV (5 page max)

The chosen nominee will submit a proposal to the sponsor by the deadline of January 13, 2023.

Any questions about this opportunity may be directed to LSO@vanderbilt.edu.


2023 NSF Innovations in Graduate Education (IGE) Program

Applications due December 15, 2022

VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Overview

VUMC may submit only 2 applications to the NSF IGE program. The Innovations in Graduate Education (IGE) program is designed to encourage the development and implementation of bold, new, and potentially transformative approaches to STEM graduate education training. The program seeks proposals that explore ways for graduate students in research-based master's and doctoral degree programs to develop the skills, knowledge, and competencies needed to pursue a range of STEM careers.

IGE focuses on projects aimed at piloting, testing, and validating innovative and potentially transformative approaches to graduate education. IGE projects are intended to generate the knowledge required for their customization, implementation, and broader adoption. The program supports testing of novel models or activities with high potential to enrich and extend the knowledge base on effective graduate education approaches.

The program addresses both workforce development, emphasizing broad participation, and institutional capacity building needs in graduate education. Strategic collaborations with the private sector, non-governmental organizations (NGOs), government agencies, national laboratories, field stations, teaching and learning centers, informal science centers, and academic partners are encouraged.

Award Information

IGE Awards are expected to be up to are expected to be up to three (3) years in duration with a total budget between $300,000 and $500,000, subject to the availability of funds.

Eligibility

VUMC may participate in two Innovations in Graduate Education proposals per competition. Participation includes serving as a lead organization on a non-collaborative proposal or as a lead organization, non-lead organization, or subawardee on a collaborative proposal.

An individual may serve as Lead Principal Investigator (PI) or Co-PI on only one proposal submitted to the IGE program per annual competition.

See the solicitation for more information.

Internal Submission Instructions

Eligible faculty interested in being one of VUMC’s nominees must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on December 15, 2022.

  1. Project Description, including summary budget (2 page max)
  2. Letter of support from department chair/center director
  3. NIH Biosketch

The chosen nominee will submit a full proposal to the foundation by the deadline of March 25, 2023.

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


2023 Ono Pharma Breakthrough Science Initiative Awards

Applications due December 15, 2022

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.

Overview:

Vanderbilt (VU + VUMC, combined) may nominate 2 candidates to submit an LOI to the Ono Pharma Foundation’s Breakthrough Science Initiative Awards Program.

Ono Pharmaceutical Co., Ltd. is a leading global healthcare company committed to delivering new, innovative pharmaceutical products to patients and championing the fight against disease and pain. The Ono Pharma Foundation was established to support academic research in relevant scientific fields, which have the potential of making significant impact on therapeutic approaches to disease and pain management.

The “Ono Initiative” is the embodiment of the Foundation’s commitment to focus on and accelerate researcher-driven open innovation by supporting high-risk and high-reward science research projects which have potential to lead to science discoveries/solutions and, possibly, based on further research, to breakthrough treatments for patients. The program seeks proposals for research that could ultimately transform human health.

Although additional areas of research may be added in future years, in 2023 the Ono Pharma Foundation will only consider proposals for scientific research projects addressing the following field of science:

Chemical Biology Research

  • Target research of Chemical Biology is not specified. Chemical Biology is defined as research that deals with the interface between chemistry and biology. The criteria for this field are deliberately broad so as not to disqualify potentially innovative and groundbreaking projects.

Award Details:

Project duration may last up to three years with annual funding of up to $300,000/year. The Foundation will provide up to a maximum of an additional 15% ($45,000) per year to be used for institutional indirect costs. The total amount of the three-year grant is up to $1,035,000.

For more information on the program, please refer to the program website and FAQs.

Eligibility Requirements:

  • The PI must have a MD and/or a PhD degree.
  • The PI must be a new applicant to the Ono Initiative, or, if they are returning, have applied over 3 years ago for a project different from the one they are currently proposing.
  • The PI must be a young and/or mid-career scientist (15 years or less from starting independent academic position).
  • The PI may not already be engaged in other sponsored research with Ono Pharmaceutical Co., Ltd. and/or grant program with Ono Pharma Foundation. (Contact LSO@vanderbilt.edu with questions.)
  • The PI may not apply for funding to amplify current work. However, PIs may research a new idea based on a prior finding of the PI.

Internal Application Process:

Anyone interested in being considered as Vanderbilt’s potential nominee(s) must submit the following as a single file (in PDF format) to LSO@vanderbilt.edu by 5:00 p.m. on December 15, 2022

  1. Brief research plan including summary budget (1-2 pages);
  2. Letter of support from department chair/center director;
  3. NIH Biosketch or Brief CV (5 page max)

Submissions should reference the program name in the subject line of the email. All applicants should verify their eligibility in advance.

If nominated by Vanderbilt, the PI must submit an LOI to the sponsor by February 15, 2023. If the LOI is reviewed favorably by Ono Pharma, then they will request a full proposal which will be due by May 17th, 2023.

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


2023 NSF Strengthening the Cyberinfrastructure Professionals Ecosystem (SCIPE)

Application due January 5th, 2023

VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Overview

VUMC may submit one application to the 2023 Strengthening the Cyberinfrastructure Professions Ecosystem (SCIPE) program. The overarching goal of this solicitation is to democratize access to NSF’s advanced cyberinfrastructure (CI) ecosystem and ensure fair and equitable access to resources, services, and expertise by strengthening how Cyberinfrastructure Professionals (CIP) function in this ecosystem. It aims to achieve this by (1) deepening the integration of CIPs into the research enterprise, and (2) fostering innovative and scalable education, training, and development of instructional materials, to address emerging needs and unresolved bottlenecks in CIP workforce development. Specifically, this solicitation seeks to nurture, grow and recognize the national CIP workforce that is essential for creating, utilizing and supporting advanced CI to enable and potentially transform fundamental science and engineering (S&E) research and education and contribute to the Nation's overall economic competitiveness and security. Together, the principal investigators (PIs), technology platforms, tools, and expert CIP workforce supported by this solicitation operate as an interdependent ecosystem wherein S&E research and education thrive.

Projects must address essential community needs, provide resources that will be widely available to and usable by the research community, and broaden participation from underrepresented groups. The intent of the SCIPE program is to encourage collaboration between CI and S&E domain disciplines.

The goals of this solicitation are to; (i) motivate the creation of researcher-facing CIP communities or affinity groups centered on S&E domains and or geographic regions with shared needs for CIPs; (ii) improve CIP workforce diversity, productivity, scalability, sustainability, and institutional career paths; (iii) promote recognition of the value of the CIP workforce to all stakeholders of S&E research; (iv) support the advancement and exchange of CIP best practices, mentoring and/or professional development and training resources across institutions; and (v) promote understanding of computation as the third pillar and data-driven science as the fourth pillar of scientific discovery.

Activities funded through this solicitation are expected to span targeted, multidisciplinary communities, and lead to transformative changes in the state of research workforce preparedness for advanced CI-enabled research in the short- and long-term. This solicitation also seeks to broaden CI access and adoption by (i) increasing the adoption of advanced CI and computational and data-driven methods to a broader range of S&E disciplines and institutions; (ii) enhancing the incorporation of CI professionals into the research enterprise – highlighting the value of those professionals in S&E research; and (iii) effectively utilizing the capabilities of individuals from a diverse set of underrepresented groups.

See the program page for more information.

Award Information

Anticipated budget amount per award is $3,750,000 for the duration of the award. Project periods are flexible.

Eligibility

To ensure relevance to community needs and to facilitate adoption, those proposals of interest to one or more domain divisions must include at least one PI/co-PI with expertise relevant to the targeted research discipline. All proposals shall include at least one PI/co-PI with expertise pertinent to the Office of Advanced Cyberinfrastructure programmatic areas of interest, found in Section II. Program Description of the solicitation.

**Prior to internal submission, interested applicants are encouraged to contact the relevant program officer(s) to determine whether the focus of their proposal is appropriate for this program.**

Internal Application Process

Eligible faculty interested in being VUMC’s nominee must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on January 5, 2023.

  1. Project Description, including summary budget (2 page max)
  2. Letter of support from department chair/center director
  3. NIH Biosketch

The chosen nominee will submit a full proposal to the sponsor by the deadline of February 23, 2023.

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


 

Research Awards Banner.png

Active Calls for NON-Limited External Opportunities 

Internal review process NOT required- Submit directly to Sponsor

The VUMC Corporate & Foundation Relations team provides hands-on proposal development assistance for non-federal awards. Contact cfr@vumc.org for more information.


Alkermes Pathways Research Awards - Schizophrenia & Bipolar I Disorder

Applications due November 30

Interested applicants are strongly encouraged to contact Jenny Alexander, Corporate & Foundation Relations (jenny.alexander@vumc.org) before starting an application.

About Pathways

With millions of people impacted by neurological disorders, more research is urgently needed to advance science in this area. The Alkermes Pathways Research Awards® program is designed to support the next generation of researchers who are working on the front lines to advance our understanding of diseases in the field of neuroscience. 

The Alkermes Pathways Research Awards® program provides opportunities for individual grants of up to $100,000 per research project for early-career investigators focused on research relating to schizophrenia or bipolar disorder.

Areas of Interest

Schizophrenia & Bipolar I Disorder

  • Preclinical, clinical, translational and epidemiological research
  • Research on treatment and patient- centered outcomes
  • Clinical and health economic outcomes using real-world data
  • Outcomes research supporting continuity of care utilizing telehealth or other technology-based approaches

Eligibility

The Alkermes Pathways Research Awards® program is for investigators who are in the early stages of their career. Research grants will be awarded to applicants who focus on and have demonstrated a commitment to schizophrenia or bipolar disorder. To be eligible, an applicant must meet the following criteria:

  • Has an M.D., Ph.D., or equivalent
  • Is affiliated with a medical or research center within the United States at the time of application
  • Is within 5 years of initial academic appointment (e.g., assistant professor) or is a current postdoctoral fellow
  • Has a research mentor with extensive experience in the field of schizophrenia or bipolar disorder
  • Has not received a DP2 award or NIH R01 grant at the time of award, but may be the recipient of a career development (K) award or other mentored research grant
  • Is willing and able to accept funding from a for-profit, biopharmaceutical company
  • Is able to complete the proposed research within 2 years
  • Is a citizen or permanent resident of the United States or holder of a temporary non-immigrant visa that is valid for the duration of the 2-year grant period

FASEB’s Excellence in Science Awards 

Nominations due December 12

FASEB’s Excellence in Science Awards honor outstanding women scientists who demonstrate commitment to the professional development of others, their scientific society, and the broader community.

FASEB presents three Excellence in Science Awards annually to recognize women scientists at different career stages. The three award categories are:

·        Lifetime Achievement (established investigators)

·        Mid-Career (within 7-15 years of first independent scientist position)

·        Early-Career (within 7 years of first independent scientist position)

Women who are current members of a FASEB full member society are eligible to be nominated for an Excellence in Science Award. Nominators must also be a current member of a FASEB full member society. The list of full member societies can be found here.

A complete list of past Excellence in Science Award recipients can be found here.

To submit a nomination, select "Start Application" in the table below.

DEADLINE: Monday, December 12

FASEB is dedicated to increasing diversity, equity, accessibility, and inclusivity within the life sciences. As part of this effort, we highly encourage nominations for individuals from historically underrepresented groups within the life sciences community.


Sanofi iDEA-iTECH Awards 

Applications due December 16

Contact CTTC for information on how to submit at cttc@vanderbilt.edu

Sanofi is a global pharmaceutical company committed to improving access to healthcare and supporting the patients we serve throughout the continuum of care. The Sanofi iDEA-iTECH Awards initiative is designed to innovate through collaborations, with a focus on cutting-edge digital and data tools and new technologies for R&D applications. 

The goal is to: 

  • Identify new collaborative projects from key academic institutions and start-ups aligned with Sanofi’s strategic areas of interest
  • De-risk cutting-edge science and technologies that can bring high potential value to R&D
  • Build strong relationships with new partners that can lead to longer-term partnerships

Each selected Investigator will receive up to $150K USD, have a dedicated Sanofi scientific expert assigned to the project for 1-year, and gain privileged access to developing an extended collaboration.

Sanofi’s main objectives in creating the iDEA-iTECH Awards program are to rapidly start one-year projects that maximize the opportunity for continued collaborations of mutual interest. Click the link below to learn more about Sanofi’s areas of interest.

The call will be open for 6 weeks and projects must be submitted by Investigators by December 16th, 2022. 


Doris Duke Physician Scientist Fellowship Program

Applications due January 13

Interested applicants are strongly encouraged to contact Sue Reeves, Foundation Relations (sue.reeves@vumc.org) before starting an application.

The Doris Duke Physician Scientist Fellowship program provides grants to physician scientists at the subspecialty fellowship level who are seeking to conduct additional years of research beyond their subspecialty requirement. The goal is to aid in the transition into a research faculty appointment.

The Physician Scientist Fellowship consists of $100,000 for annual direct costs plus $10,000 (10%) for annual indirect costs for two years. The priority of the Physician Scientist Fellowship program is to fund outstanding individuals with excitement for clinical research careers, whose projects will address highly significant research questions and lead to career advancement. DDCF does not have funding priorities for this fellowship based on disease area or research type. To see previous awardees of the Physician Scientist Fellowship, please visit our searchable Grant Recipients database.

In keeping with the wishes expressed in Doris Duke's will, experiments that use animals or tissues derived from animals, including cell lines, are not supported by this program.


Breast Cancer Research Foundation - Precision Prevention Initiative

Applications due January 16

Program Overview

The overarching goal of this initiative is to fuel innovation and accelerate breast cancer prevention research by challenging the research community to think boldly; to explore multidisciplinary approaches to get the answers in less time, utilize new technologies or identify new ways to examine available data, and to build or enhance infrastructure, resources, and tools that will facilitate innovation in prevention research for years to come.
With this RFA, we are soliciting applications in three primary areas for impact: 1) Risk Assessment and Stratification; 2) Biomarkers; 3) Interventions

Grant Types

  • Innovation Grants. Innovation grants are intended to provide a single investigator the opportunity to expand into a new area of discovery in primary breast cancer prevention. Well-designed and conceived high risk-high reward concepts that challenge current paradigms are encouraged. Projects must have a high likelihood of translation if successful and address an unmet need in breast cancer prevention research. These awards provide up to $250,000 per year for two years ($500,000 total), including maximum IDC not exceeding 20 percent of total direct costs.
  • Pre-Clinical Grants. These awards are for translational research that has a direct application or with a clear path to significantly impact breast cancer prevention. The intention is to enable the applicant to integrate advanced technologies or experimental systems that may not be feasible at the lower Innovation budget. Projects may be supplemental to current funding but should expand the applicant’s research question to be specific to this RFA. Investigators working outside the prevention field and multidisciplinary teams are encouraged to apply. These awards provide up to $500,000 per year for three years ($1,500,000 total), including maximum IDC not exceeding 20 percent of total direct costs.
  • Clinical Trial or Intervention Study Grants. These awards are for a single investigator or investigator team to support a clinical trial or intervention focused on the prevention of breast cancer. The study must include one or more human subjects prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes. These awards provide up to $750,000 per year for three years ($2,250,000), including maximum IDC not exceeding 20 percent of total direct costs.

Key Dates

  • Application submission period opens: November 16, 2022
  • Letter of Intent (LOI) Due: January 16, 2023
  • Invitation to submit full proposals: Notifications by March 3, 2023
  • Full Proposal due: April 28, 2023 (invited LOIs only)
  • Award notification date: August 7, 2023
  • Award Start Date: October 1, 2023

Simons Foundation Autism Research Initiative - 2023 Bridge to Independence Award

Letters of Intent due February 16

Informational webinar December 8

The Simons Foundation Autism Research Initiative (SFARI) is pleased to announce the 2023 Bridge to Independence Award request for applications (BTI RFA).

The BTI Award program engages talented early-career scientists in autism research by facilitating their transition to research independence and providing grant funding at the start of their professorships at a US or international institution. Awardees receive up to two years of postdoctoral fellowship support with an annual salary of $70,000 and an annual resource and professional development allowance of $10,000, followed by a commitment of $600,000 over three years, activated upon assumption of a tenure-track research professorship.

This RFA is aimed at scientists with a Ph.D. and/or M.D. who are currently in training positions but intend to seek tenure-track research faculty positions in the next academic cycle.

We welcome applications that span the breadth of science that SFARI normally supports, including genetics, molecular mechanisms, circuits and systems, and clinical science. We encourage applications from scientists who are currently working in the autism field, as well as those who are new to autism.

Applications from groups that have been historically underrepresented or excluded in the biomedical workforce — including but not limited to racial and ethnic groups, sexual orientation and gender identities, individuals with mental/physical disabilities, and those from economically disadvantaged backgrounds — are encouraged.

The deadline for letters of intent and letters of recommendation is February 16, 2023. Detailed information and application instructions are available here.

An informational session for prospective applicants will be held on December 8, 2022 at 12:00 p.m. EST, registration here.


NIH Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)

Applications due February 16 (Additional cycles shown on the FOA)

 

This Trailblazer Award is an opportunity for NIH-defined New and Early Stage Investigators (https://grants.nih.gov/policy/early-investigators/index.htm) to pursue research programs that integrate engineering and the physical sciences with the life and/or biomedical sciences. A Trailblazer project may be exploratory, developmental, proof of concept, or high risk-high impact, and may be technology design-directed, discovery-driven, or hypothesis-driven. Importantly, applicants must propose research approaches for which there are minimal or no preliminary data.

A distinct feature for this FOA is that no preliminary data are required, expected, or encouraged. However, if available, minimal preliminary data are allowed. Preliminary data are defined as material which the applicant has independently produced and not yet published in a peer-reviewed journal. All preliminary data should be clearly marked and limited to one-half page, which may include one figure. Applications including data more than one-half page or more than one figure will be considered noncompliant with the FOA instructions and will not go forward to review.

This Funding Opportunity Announcement (FOA) employs an R21 Exploratory/Developmental Research Grant mechanism enhanced to provide $400,000 in direct costs over three years, allowing expanded time and resources to pursue a new or emerging research program.

This award is sponsored by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Eye Institute (NEI) and National Institute on Aging (NIA). Each institute has specific areas of research interest - see FOA for more details.


Simons Foundation - Neuroscience Collaborations

Vision statements due March 8

Informational webinar December 12

Overview

The Simons Foundation seeks to create strong collaborations and foster the cross-pollination of ideas between investigators, as these interactions often lead to unexpected breakthroughs. Towards this end, in 2012 the foundation launched a new collaborative funding model, the Simons Collaborations, which funds groups of investigators — often from different disciplines — to work together on a timely and important problem. To date, 23 Simons Collaborations have been launched in and across our Mathematics and Physical Sciences, Life Sciences and Neuroscience divisions, and another two collaborations through the Simons Foundation Autism Research Initiative (SFARI).

The goal of the Simons Collaborations is to bring together groups of outstanding scientists to address topics of fundamental scientific importance, with a focus on fields in which significant new developments have created novel opportunities for exploration. To enable bold, creative and innovative research, each collaboration is funded for ten years (with a review at year five).

Call for Collaborations

We now seek vision statements to identify new, emerging breakthrough areas of neuroscience that are poised for high-impact funding by the Simons Foundation. We are interested in bold and cutting edge, idea-generating research that focuses on basic principles of brain function and may be overlooked or too risky for other funding organizations.

We will prioritize cross-disciplinary collaborations that integrate many levels of analysis, methodologies, ways of thinking, and scientific communities. We endeavor to encourage conversations within and across fields while bringing together diverse groups of researchers to investigate important questions about the basic principles of brain function. Investigators in a Simons Collaboration are expected to openly share data, code, analysis pipelines, protocols and reagents. We expect proposals to include junior investigators and investigators from a diversity of academic disciplines, genders, races and ethnicities in a Simons Collaboration.

Vision statements should clearly outline the big idea and hypotheses that the proposed neuroscience collaboration will address, including high-level overviews of the methods and approaches that will be used. Why is this work uniquely suited for Simons Collaboration funding? Why should this collaboration be funded now? Why is it difficult to obtain funding to investigate these questions from other funding agencies and foundations? Vision statements should address why and how the support of a large collaborative research project from the Simons Foundation will transform our understanding of how the brain works. Please propose investigators who may be included in the collaboration and an estimated anticipated overall yearly total cost.

Vision statements should be no longer than two-pages, single-spaced, 11 pt New Times Roman font, 0.5 in margins plus one page (if needed) of figures, references, the anticipated overall yearly total cost and list of proposed PIs.

Funding Levels and Period
Simons Collaborations will be funded for 10 years (with a review at year 5). The total budget for the new Neuroscience Collaborations will be $25 million per year. We anticipate identifying up to three collaborations, with the funding level of each collaboration determined by the proposed scope and aims of the project. As a guideline, we suggest budgets of between $5–12 million per year, inclusive of 20 percent indirect costs.

Eligibility
All investigators must hold a Ph.D., M.D. or equivalent degree and have a faculty position or the equivalent (eligible for receiving grant funding) at a college, university, medical school or other research facility. In addition, eligible applicants must have independent research space at their institution.


National Center for Medical Rehabilitation Research (NCMRR) Early Career Research Award (R03 Clinical Trial Optional)

Applications due March 28

The NCMRR Early Career Research (ECR) Award is different from other NIH R03 programs, including the Parent R03 Announcement. It is restricted to clinical and basic scientists who are in the early stages of their independent career in rehabilitation research. For projects supported by a ECR R03 Award, successful results should provide a solid foundation for further research under the R01 funding mechanism.

Given that the goal is to collect preliminary data, R03 projects may be less immediately impactful or significant compared to the typical R01 or other NIH-funded projects. It is not an expectation that this R03 project will likely "move the field forward" at this stage.

The research must be focused on one or more of the areas within the biomedical and behavioral mission of NCMRR: pathophysiology and management of chronically injured nervous and musculoskeletal systems (including stroke, traumatic brain injury, spinal cord injury, and orthopedic conditions); repair and recovery of motor function; functional plasticity, adaptation, and windows of opportunity for rehabilitative interventions; rehabilitative strategies involving pharmaceutical, stimulation, and neuroengineering approaches, exercise, motor training, and behavioral modifications; pediatric rehabilitation; secondary conditions associated with chronic disabilities; improved diagnosis, assessment, and outcome measures; and development of orthotics, prosthetics, and other assistive technologies and devices.

The following topics are non-responsive and will be withdrawn prior to review:

  • Projects focusing on cognitive rehabilitation without a physical rehabilitation component
  • Sports medicine rehabilitation for people without physical disabilities (i.e. Projects targeting indications for sports or athletic performance by able-bodied athletes; treatment, recovery and prevention of injuries related to sports and exercise by people without physical disabilities.) 

The proposed project may be technology design-directed, discovery-driven, or hypothesis-driven with the goal of collecting the necessary preliminary data sufficient to apply for an R01 grant. The project may aid in the formulation of hypotheses and may be milestone-driven or descriptive in scope. Preliminary data are not required or expected. However, if available, preliminary data are allowed.

The total budget (direct costs) is up to $200,000 spread over two years. No more than $100,000 in direct costs may be requested in any single year.


HESI THRIVE - Making Cancer Patient Quality of Life an Active Research Priority

Letters of intent due April 10

THRIVE, a 2018 proud partner of the Biden Cancer Initiative, provides seed grants for clinical and translational research and technology-based solutions that enhance our ability to predict when and how adverse effects may occur in patients who have received cancer treatment. THRIVE also supports the development of approaches to avoid or lessen these effects. 

THRIVE is interested in research that will advance our:
•    Fundamental understanding of cancer drug or therapy-related toxicity
•    Ability to identify and translate critical biomarkers of toxicity
•    Models (in vitro, in vivo, in silico) of pediatric or adult drug exposure that predict early or impending toxicities 
•    Understanding the role of protective co-therapies or modified exposure protocols on the onset of therapy-induced damage; and
•    Identification of novel protective therapies or dosing strategies.

ELIGIBILITY
•    PI's must hold an MD, PhD, DVM or equivalent degree. Candidates for these degrees along with their PI may apply.
•    Candidates must have the ability to conduct independent research and have published in peer-reviewed journals.
     
FUNDING
•    Range of $20,000 - $50,000 for up to 24 months 
•    Upon agreement to THRIVE award terms, THRIVE will disburse 75% of funds with the remaining provided upon completion of the study milestones.

APPLICATION PROCESS
•    All letters of intent and grant applications are to be submitted through the Proposal Central website here
•    If you are a new user to ProposalCentral, follow the Need an account? link and complete the registration process.   
 
SELECTION PROCESS
•    The proposed study's scientific merit, innovation, and ability to translate pre-clinical to clinical research (or vice versa) is key to being selected for funding. 
•    Preference given to studies in which both a non-clinical and a clinical researcher are engaged in either the design, conduct, or analysis of the study results. Click here for Grant Guidelines
•    A total of 3 - 4 grants will be awarded in 2023.